The California life sciences sector creates new medicines that save lives, which benefits patients and their families, the healthcare system and the economy. In the last century, innovative therapies have extended the average lifespan from 58 to 79 and improved overall health and quality of life.
California has an exceptional history of producing thousands of new, advanced therapies and technologies designed to treat cancer, diabetes, the immune system and central nervous disorders – just to name a few. In 2017, 4,800+ science and engineering PhDs have graduated from California institutions, 1,274 new therapies are in the pipeline from California companies, and 440 medical devices created by California companies were approved by the FDA to improve patient health and well-being.
Life sciences innovation helps patients, and it also drives the economy: California’s research institutions combine with a unique entrepreneurial spirit to develop new technologies, attract investors and push the state’s economy to greater heights.
By encouraging our California and federal legislators to support pro-innovation policy outcomes, we can accelerate the pace of innovation and reduce barriers that hurt patient access to important new medicines and technologies.